Mingyi Ju

678 total citations
17 papers, 439 citations indexed

About

Mingyi Ju is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mingyi Ju has authored 17 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mingyi Ju's work include Cancer Immunotherapy and Biomarkers (8 papers), Ferroptosis and cancer prognosis (7 papers) and RNA modifications and cancer (4 papers). Mingyi Ju is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Ferroptosis and cancer prognosis (7 papers) and RNA modifications and cancer (4 papers). Mingyi Ju collaborates with scholars based in China, Saint Kitts and Nevis and United States. Mingyi Ju's co-authors include Lin Zhao, Jingyi Fan, Minjie Wei, Xinyue Song, Longyang Jiang, Qian Wei, Liwu Fu, Marcia Bellon, Christophe Nicot and Qiutong Guan and has published in prestigious journals such as The FASEB Journal, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Immunology.

In The Last Decade

Mingyi Ju

17 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingyi Ju China	11	301	170	150	143	101	17	439
Xiangli Jiang China	14	307 1.0×	171 1.0×	222 1.5×	171 1.2×	45 0.4×	23	512
Zhenqian Wu China	11	169 0.6×	118 0.7×	98 0.7×	178 1.2×	72 0.7×	16	368
Zhiying Zheng China	8	235 0.8×	164 1.0×	176 1.2×	143 1.0×	146 1.4×	15	439
Fuzhou Tang China	10	220 0.7×	226 1.3×	101 0.7×	159 1.1×	126 1.2×	24	459
Jin‐Ling Duan China	13	265 0.9×	93 0.5×	139 0.9×	105 0.7×	52 0.5×	29	407
Wenqing Feng China	10	204 0.7×	84 0.5×	125 0.8×	169 1.2×	66 0.7×	25	385
Archana Sehrawat United States	8	195 0.6×	136 0.8×	67 0.4×	173 1.2×	111 1.1×	10	398
Teming Zhang China	6	135 0.4×	114 0.7×	89 0.6×	160 1.1×	110 1.1×	10	324

Countries citing papers authored by Mingyi Ju

Since Specialization

Citations

This map shows the geographic impact of Mingyi Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyi Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyi Ju more than expected).

Fields of papers citing papers by Mingyi Ju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyi Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyi Ju. The network helps show where Mingyi Ju may publish in the future.

Co-authorship network of co-authors of Mingyi Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyi Ju. A scholar is included among the top collaborators of Mingyi Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyi Ju. Mingyi Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ju, Mingyi, Weiwei Tong, Jia Bi, et al.. (2025). Hydrogen Sulfide Promotes TAM‐M1 Polarization through Activating IRE‐1α Pathway via GRP78 S‐Sulfhydrylation to against Breast Cancer. Advanced Science. 12(8). e2413607–e2413607. 3 indexed citations

Ju, Mingyi, et al.. (2024). Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy. Journal for ImmunoTherapy of Cancer. 12(7). e009345–e009345. 5 indexed citations

Li, Yunong, et al.. (2023). Advancement of anti‐LAG ‐3 in cancer therapy. The FASEB Journal. 37(11). e23236–e23236. 14 indexed citations

Song, Jia, et al.. (2023). Molecular interplay between EIF4 family and circular RNAs in cancer: Mechanisms and therapeutics. European Journal of Pharmacology. 954. 175867–175867. 8 indexed citations

Ju, Mingyi, Jingyi Fan, Longyang Jiang, et al.. (2022). Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer. Frontiers in Immunology. 13. 807840–807840. 7 indexed citations

Fan, Jingyi, Marcia Bellon, Mingyi Ju, et al.. (2022). Clinical significance of FBXW7 loss of function in human cancers. Molecular Cancer. 21(1). 87–87. 89 indexed citations

Wang, Lin, Xueping Li, Longyang Jiang, et al.. (2021). Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer. Pathology & Oncology Research. 27. 596899–596899. 11 indexed citations

Song, Xinyue, Xue Jiao, Yan Han, et al.. (2021). Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity. Frontiers in Cell and Developmental Biology. 9. 622018–622018. 15 indexed citations

Song, Xinyue, Lin Wang, Mingyi Ju, et al.. (2021). m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma. Frontiers in Oncology. 11. 598017–598017. 10 indexed citations

10.

Wang, Ding, Ju Ma, Xinyue Song, et al.. (2021). Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. BMC Cancer. 21(1). 645–645. 94 indexed citations

11.

Ju, Mingyi, Yinfeng Liu, Jia Bi, et al.. (2021). Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer. Pathology & Oncology Research. 27. 600727–600727. 5 indexed citations

12.

Ju, Mingyi, Longyang Jiang, Wei Qian, et al.. (2021). A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer. OncoTargets and Therapy. Volume 14. 5065–5083. 13 indexed citations

13.

Qian, Wei, Xueping Li, Mingyi Ju, et al.. (2020). Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma. Cancer Medicine. 9(21). 8186–8201. 18 indexed citations

14.

Ju, Mingyi, Jia Bi, Qian Wei, et al.. (2020). Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer. Briefings in Bioinformatics. 22(4). 118 indexed citations

15.

Ju, Mingyi, Jia Bi, Lan Zhao, et al.. (2020). A five‐mRNA signature associated with post‐translational modifications can better predict recurrence and survival in cervical cancer. Journal of Cellular and Molecular Medicine. 24(11). 6283–6297. 14 indexed citations

16.

Qian, Wei, Chenyi Zhou, Mingyi Ju, et al.. (2020). Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma. International Immunopharmacology. 89(Pt A). 107162–107162. 14 indexed citations

17.

Craft, Jeffrey M., Junsang Oh, Mingyi Ju, et al.. (2010). Quantitative Mass Spectroscopy and the Identification of Alpha2macroglobulin as a Potential Biomarker for Radiation Pneumonitis. International Journal of Radiation Oncology*Biology*Physics. 78(3). S498–S499. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangli Jiang Breakdown of academic impact, for papers by Zhenqian Wu Breakdown of academic impact, for papers by Zhiying Zheng Breakdown of academic impact, for papers by Fuzhou Tang Breakdown of academic impact, for papers by Jin‐Ling Duan Breakdown of academic impact, for papers by Wenqing Feng Breakdown of academic impact, for papers by Archana Sehrawat Breakdown of academic impact, for papers by Teming Zhang